Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:59:18.956Z.
Calculation as of: 2026-10-06T20:59:18.956Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 48a9c173a70739b1093346a936f860d9c8f80d7eeb2565194c7199b3c596865c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$376.01M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.50M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$380.37M
Free Cash Flow Yield
N/A
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
3.89%
Market Cap
$369.50M
Free Cash Flow Yield
N/A
TTM Avg
13.37%
3Y Avg
10.70%
5Y Avg
10.70%
Market Cap
$385.15M
Free Cash Flow Yield
N/A
TTM Avg
11.28%
3Y Avg
11.28%
5Y Avg
6.55%
Market Cap
$359.53M
Free Cash Flow Yield
N/A
TTM Avg
15.24%
3Y Avg
15.24%
5Y Avg
15.24%
Market Cap
$396.93M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zura Bio Limited (ZURA) | $376.19M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.01M | N/A | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | N/A | 0.08% | 0.08% | 3.89% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | N/A | 13.37% | 10.70% | 10.70% |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | N/A | 11.28% | 11.28% | 6.55% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | N/A | 15.24% | 15.24% | 15.24% |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | N/A | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
